Analyst Research

Report Title Price
Thomson Reuters Stock Report - CHUBB CORPORATION (THE) (CB-N)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Detailed Valuation Report for CB
Provider: ValuEngine, Inc.
$127.00
Buy
Trading Report for (CB). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
$58.00
Buy
The Investment Rate - a measure of investment demand.
Provider: Stock Traders Daily
$495.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Johnson & Johnson To Sell Off Diagnostics Unit-Reuters


Tuesday, 22 Jan 2013 02:29pm EST 

Reuters reported that Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the Company said when it reported quarterly earnings. The diversified healthcare company said it may sell the Ortho Clinical Diagnostics business - whose products include equipment for laboratory diagnostics and blood transfusion screening - or turn it into a stand-alone company. 

Latest Developments for Chubb Corp

Latest Key Developments in Insurance

Company Quote

Chubb Corp
(CB.N)
87.82
-0.19 -0.22%
23 May 2013